Autres langues PaxMedica, Inc.

Actions

PXMD

US70424C2035

Marché Fermé - Nasdaq Autres places de cotation 22:00:00 23/04/2024			Varia. 5j.	Varia. 1 janv.
0,716 ^USD	-4,83 %		+8,48 %	-5,42 %

16/04	PaxMedica, Inc. reçoit une demande urgente de suramine IV de la part du ministère africain de la santé pour le traitement de la maladie du sommeil mortelle	CI
12/04	Mise à jour sectorielle : Les actions du secteur de la santé en baisse en fin d'après-midi	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

PaxMedica Responds to Emergency Request for IV Suramin and Commits to Provide Immediate Access to PAX-101	23/04
PaxMedica Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness	16/04
PaxMedica, Inc. Receives Emergency Request for IV Suramin from African Health Ministry for Use in Treating Fatal Sleeping Sickness	16/04
Sector Update: Health Care Stocks Slipping Late Afternoon	12/04
Top Midday Gainers	12/04
Major US Banks' Lower Earnings Drag Down Exchange-Traded Funds, Equity Futures Pre-Bell Friday	12/04
PaxMedica Achieves Key Milestone in the Development of PAX-101 And Provides Update on Potential NDA Submission	11/04
PaxMedica, Inc. Achieves Key Milestone in the Development of Pax-101 and Provides Update on Potential NDA Submission	11/04
PaxMedica : Certificate of Incorporation/Bylaws - Form 8-K	22/03
PaxMedica Updated Company Presentation Highlighting Innovations in Autism Spectrum Disorder Treatments	13/03
PaxMedica, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	11/03
Certain Warrants of PaxMedica, Inc. are subject to a Lock-Up Agreement Ending on 19-FEB-2024.	19/02
Certain Common Stock of PaxMedica, Inc. are subject to a Lock-Up Agreement Ending on 19-FEB-2024.	19/02
PaxMedica Raises $7 Million From Public Offering	22/11
Sector Update: Health Care Stocks Advance in Late Afternoon Trading	20/11
Top Midday Decliners	20/11
Sector Update: Health Care Stocks Advance in Afternoon Trading	20/11
PaxMedica Prices $7 Million Public Offering of Shares, Warrants; Stock Slumps	20/11
PaxMedica Inc. Featured in Syndicated Broadcast Highlighting FDA Type-B Meeting to Review PAX-101 Pivotal Trial Data	17/11
PaxMedica, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	16/11

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues PaxMedica, Inc.

Actions

PXMD

US70424C2035

Autres langues

Filtres